Stay updated on Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial page.

Latest updates to the Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial page
- CheckyesterdayChange DetectedA new revision label v3.6.5 is added to the history, superseding the previous v3.6.4.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSponsor/collaborators were updated: Astellas (Beijing) Pharmaceutical R&D Co., Ltd. and Astellas Pharma Inc (Astellas (Beijing) Pharmaceutical R&D Co., Ltd.) were added, while Astellas Pharma China, Inc. and Astellas Pharma Inc (Astellas Pharma China, Inc.) were removed. This aligns with a new revision (v3.6.4) dated 2026-07-24 and a related Study Status update on 2026-07-22.SummaryDifference0.4%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedA new revision (v3.6.3) was added to the Record History, updating the page's version history. The previous revision (v3.6.0) is no longer listed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now shows that the trial is not seeking participants anymore. A new revision (v3.6.0) was added and the prior revision (v3.5.5) was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page history now shows Revision: v3.5.5, replacing v3.5.4. This reflects a small update to the page's revision metadata rather than changes to the study information or visible content.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry (v3.5.4) was added to the Study Record Versions list, reflecting a system update to the page's revision history rather than changes to trial content.SummaryDifference0.1%

Stay in the know with updates to Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial page.